We recently compiled a list of the Jim Cramer Shed Light on These 10 Stocks. In this article, we are going to take a look at ...

Abbott Laboratories ABT faced industry-wide challenges that exerted pressure on its profit margins. Factors such as rising ...

The last few weekends have been roiled by headlines. Here's why we took a different direction on this medical stock this week ...

Abbott is in Washington this week to lobby Congress for $11 billion to compensate Texas for money spent on his Operation Lone ...

His fears were that Abbott (NYSE:ABT) might pull the product entirely rather than risk further lawsuits—just like Johnson & ...

We recently compiled a list of the Jim Cramer Highlighted Buying Opportunities in 13 Stocks. In this article, we are going to ...

The stock's fall snapped a three-day winning streak.